Patents Represented by Attorney, Agent or Law Firm Robert D. Fish
  • Patent number: 6525191
    Abstract: L-nucleosides are conformationally constrained by at least one additional ring formed by a bridge connecting at least two atoms within a sugar moiety of the nucleoside. While a single additional ring is formed by bridging C1-C4 atoms, two additional rings are formed by bridging both C1-C2, and C3-C4 atoms, or C1-C3 and C2-C4 atoms by bridges having the general structure A—B—Z. The conformationally constrained nucleosides may be incorporated into oligonucleotides and dinucleotides, and it is contemplated that compositions including the conformationally constrained nucleosides may have superior viral inhibitory or antineoplastic properties.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: February 25, 2003
    Inventor: Kanda S. Ramasamy
  • Patent number: 6518253
    Abstract: A 1-(&bgr;-L-ribofuranosyl)-1,2,4-triazole-3-carboxamide is administered in a method of treatment of a viral infection in a patient, including HIV infection, HCV infection, or BHV infection.
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: February 11, 2003
    Inventor: Robert Tam
  • Patent number: 6517951
    Abstract: A process for forming a planarization film on a substrate that does not smoke or fume on heating includes applying a polymeric solution including a novolac resin having a weight average molecular weight between about 1000 and 3000 amu, which has been fractionated to remove molecules with molecular weight below about 350 amu, a surfactant selected from a group consisting of a non-fluorinated hydrocarbon, a fluorinated hydrocarbon and combinations thereof, and an optional organic solvent to a substrate, followed by heating the substrate.
    Type: Grant
    Filed: December 12, 2000
    Date of Patent: February 11, 2003
    Assignee: Honeywell International Inc.
    Inventors: Nigel Hacker, Todd Krajewski, Richard Spear
  • Patent number: 6512071
    Abstract: An organohydridosiloxane polymer having a cage conformation, at least approximately 40 Mole percent carbon containing substituents and a dielectric constant of less than about 2.7 is presented. Each silicon atom of the cage polymer is bonded to at least three oxygen atoms and to either a hydrogen atom or an organic substituent. By providing such a caged structure with essentially no hydroxyl or alkoxy substituents, either on the polymer backbone or at terminal silicon atoms, essentially no chain lengthening polymerization can occur in solution. Such organohydridosiloxane resins having a molecular weight in the range from about 400 to about 200,000 atomic mass units were formed using a dual phase solvent system and either a solid phase or phase transfer catalyst to assist the condensation of hydridotrihalosilane with at least one organotrihalosilane.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: January 28, 2003
    Assignee: Honeywell International Inc.
    Inventors: Nigel P. Hacker, Scott Lefferts, Lisa Figge
  • Patent number: 6509415
    Abstract: A low dielectric constant material has a first backbone with an aromatic moiety and a first reactive group, and a second backbone with an aromatic moiety and a second reactive group, wherein the first and second backbones are crosslinked via the first and second reactive groups in a crosslinking reaction without an additional crosslinker, and wherein a cage structure having at least 10 atoms is covalently bound to at least one of the first and second backbone.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: January 21, 2003
    Assignee: Honeywell International Inc.
    Inventors: Kreisler Lau, Feng Quan Liu, Boris Korolev, Emma Brouk, Rusian Zherebin, Roger Leung
  • Patent number: 6509320
    Abstract: Novel purine L-nucleoside compounds are disclosed, in which both the purine rings and the sugar are either modified, functionalized or both. The novel compounds or pharmaceutically acceptable esters or salts thereof may be used in pharmaceutical compositions, and such compositions may be used to treat an infection, an infestation, a neoplasm, or an autoimmune disease. The novel compounds may also be used to modulate aspects of the immune system, including modulation of Th1 and Th2.
    Type: Grant
    Filed: June 15, 2000
    Date of Patent: January 21, 2003
    Assignee: ICN Pharmaceuticals, Inc.
    Inventors: Guangyi Wang, Robert Tam, Devron Averett
  • Patent number: 6509063
    Abstract: Novel polyindanebisphenols or PIBPs for the preparation of new and improved thermosetting polymers having the general formula of are provided. Also disclosed are thermoplastic or thermoset compositions prepared using the novel compounds of the invention, as well as methods of making and using the same. When copolymerized or reactive with other commercial resins such as, e.g., epoxy compounds, PIBP based polymers are characterized by high glass transition temperature (“Tg”), low dielectric constant, low moisture absorption, low coefficient of expansion, low cost, and can be processed on equipment typically used for the production of epoxy based laminates.
    Type: Grant
    Filed: September 6, 2000
    Date of Patent: January 21, 2003
    Assignee: Honeywell International Inc.
    Inventors: Thomas Fitzgerald McCarthy, David Schwind, Gordon Smith
  • Patent number: 6510392
    Abstract: Methods and apparatus for improved impedance measurements are which allow for shorter delays during recalibration and which eliminate the need to physically disconnect and reconnect test leads after initial calibration has been completed. In particular, an adjustment factor is calculated based on impedances measured during initial calibration and is used to adjust future impedance measurements. Moreover, a plurality of loads having pre-measured impedances are switchably connected to the meter such that re-calibration using said loads may be accomplished without the physical connection or disconnection of test leads. The plurality of loads are preferably incorporated into a test board which also comprises additional test leads and a switching mechanism to alternately connect the various loads and test leads to the meter.
    Type: Grant
    Filed: December 28, 2000
    Date of Patent: January 21, 2003
    Assignee: Honeywell Advanced Circuits, Inc.
    Inventors: Yutaka Doi, Stephen L. Tisdale
  • Patent number: 6506497
    Abstract: Anti-reflective coating materials for deep ultraviolet photolithography include one or more organic light-absorbing compounds incorporated into spin-on-glass materials. Suitable absorbing compounds are strongly absorbing over wavelength ranges around wavelengths such as 365 nm, 248 nm, and 193 nm that may be used in photolithography. A method of making absorbing spin-on-glass materials includes combining one or more organic absorbing compounds with alkoxysilane or halosilane reactants during synthesis of the spin-on-glass materials.
    Type: Grant
    Filed: January 26, 2000
    Date of Patent: January 14, 2003
    Assignee: Honeywell International Inc.
    Inventors: Joseph Kennedy, Teresa Baldwin, Nigel P. Hacker, Richard Spear
  • Patent number: 6506332
    Abstract: A method for filling vias in an electronic substrate which includes providing a source of fill material; providing a pressure head coupled to the source of fill material via a fill material inlet, the pressure head further comprising an elongated fill material outlet which is substantially larger than the fill material inlet; placing the pressure head in contact with the electronic substrate; and pressurizing the fill material to inject fill material into the vias of the electronic substrate.
    Type: Grant
    Filed: December 28, 2000
    Date of Patent: January 14, 2003
    Assignee: Honeywell International Inc.
    Inventor: Jesse L. Pedigo
  • Patent number: 6506441
    Abstract: A process for forming a planarization film on a substrate that does not smoke or fume on heating includes applying a polymeric solution including a novolac resin having a weight average molecular weight between about 1000 and 3000 amu, which has been fractionated to remove molecules with molecular weight below about 350 amu, a surfactant selected from a group consisting of a non-fluorinated hydrocarbon, a fluorinated hydrocarbon and combinations thereof, and an optional organic solvent to a substrate, followed by heating the substrate.
    Type: Grant
    Filed: December 12, 2000
    Date of Patent: January 14, 2003
    Assignee: Honeywell International Inc.
    Inventors: Nigel Hacker, Todd Krajewski, Richard Spear
  • Patent number: 6506831
    Abstract: A process for forming a planarization film on a substrate that does not smoke or fume on heating includes applying a polymeric solution including a novolac resin having a weight average molecular weight between about 1000 and 3000 amu, which has been fractionated to remove molecules with molecular weight below about 350 amu, a surfactant selected from a group consisting of a non-fluorinated hydrocarbon, a fluorinated hydrocarbon and combinations thereof, and an optional organic solvent to a substrate, followed by heating the substrate.
    Type: Grant
    Filed: December 2, 1998
    Date of Patent: January 14, 2003
    Assignee: Honeywell International Inc.
    Inventors: Nigel Hacker, Todd Krajewski, Richard Spear
  • Patent number: 6500566
    Abstract: A method for making a metal-clad laminate product including: providing a carrier film; depositing directly onto the carrier film a release agent layer, the release agent layer comprising an aqueous soluble polymer; forming a conductive metal layer on the release agent layer, the metal layer having a thickness of less than about 10,000 Angstroms; bonding the metal layer to a circuit board laminate layer; and removing the carrier film from the metal layer by peeling the carrier layer from the release agent layer.
    Type: Grant
    Filed: September 12, 2000
    Date of Patent: December 31, 2002
    Assignee: Honeywell International Inc.
    Inventor: Gordon Smith
  • Patent number: 6495677
    Abstract: Nucleosides, novel nucleoside analog compounds and their novel prodrug forms are disclosed. The novel compounds, prodrugs, or pharmaceutically acceptable esters or salts thereof may be used in pharmaceutical compositions, and such compositions may be used to treat an infection, an infestation, a neoplasm, or an autoimmune disease. The novel compounds may also be used to modulate aspects of the immune system, including modulation of Type 1 and Type 2 activity.
    Type: Grant
    Filed: June 16, 2000
    Date of Patent: December 17, 2002
    Inventors: Kanda S. Ramasamy, Guangyi Wang, Johnson Lau
  • Patent number: 6489184
    Abstract: Methods and apparatus are provided which decrease the amount of movement likely to occur during processing of a substrate. In particular, a horizontally supported dielectric panel is subjected to a series of processing steps during which the panel is heated, cooled, or maintained at a fixed temperature so as to a achieve a 2 to 1 reduction in material movement during subsequent processing. It is contemplated that application of the disclosed methods to a dielectric panel will be particularly beneficial when application is accomplished prior to laser drilling and sputtering the panel.
    Type: Grant
    Filed: April 20, 2000
    Date of Patent: December 3, 2002
    Assignee: Honeywell International Inc.
    Inventors: Richard Pommer, Glen Roeters, Jim Yardley
  • Patent number: 6489380
    Abstract: Compositions having high moisture resistance and flexibility comprise an organic component and a filler. The organic component comprises a long-chain cycloaliphatic epoxy resin, a short-chain cycloaliphatic epoxy resin, a cyanate ester, and a Lewis acid catalyst. Preferably the organic component further comprises a Bronsted acid co-catalyst and/or a flexibilizing modifier. The compositions are useful in various semiconductor applications, including as die attach adhesives, underfills, encapsulants, via fills, prepreg binders, polymer solder masks and polymer bumps on flip chip or BGA assemblies.
    Type: Grant
    Filed: April 27, 2000
    Date of Patent: December 3, 2002
    Assignee: Johnson Matthey Electronics, Inc.
    Inventors: Xiao-Qi Zhou, Henry Wevick, Nancy E. Iwamoto, Shao Wei Li, Alan Grieve
  • Patent number: 6479463
    Abstract: Novel purine L-nucleoside compounds are disclosed, in which both the purine rings and the sugar are either modified, functionalized or both. The novel compounds or pharmaceutically acceptable esters or salts thereof may be used in pharmaceutical compositions, and such compositions may be used to treat an infection, an infestation, a neoplasm, or an autoimmune disease. The novel compounds may also be used to modulate aspects of the immune system, including modulation of Th1 and Th2.
    Type: Grant
    Filed: June 16, 2000
    Date of Patent: November 12, 2002
    Assignee: ICN Pharmaceuticals, Inc.
    Inventors: Guangyi Wang, Robert Tam, Devron Averett
  • Patent number: 6469123
    Abstract: In a method of producing a low dielectric constant polymer, a thermosetting monomer is provided, wherein the thermosetting monomer has a cage compound or aryl core structure, and a plurality of arms that are covalently bound to the cage compound or core structure. In a subsequent step, the thermosetting monomer is incorporated into a polymer to form the low dielectric constant polymer, wherein the incorporation into the polymer comprises a chemical reaction of a triple bond that is located in at least one of the arms. Contemplated cage compounds and core structures include adamantane, diamantane, silicon, a phenyl group and a sexiphenylene group, while preferred arms include an arylene, a branched arylene, and an arylene ether. The thermosetting monomers may advantageously be employed to produce low-k dielectric material in electronic devices, and the dielectric constant of the polymer can be controlled by varying the overall length of the arms.
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: October 22, 2002
    Assignee: Honeywell International Inc.
    Inventors: Kreisler S. Lau, Feng Quan Liu, Boris A. Korolev, Emma Brouk, Ruslan Zherebin, David Nalewajek
  • Patent number: 6464740
    Abstract: An aqueous metal oxide sol slurry has been developed for removal of low dielectric constant materials. The slurry is formed directly in solution utilizing non-dehydrated chemically active metal oxide sols which are formed in a colloidal suspension or dispersion. The oxide sols have not undergone any subsequent drying and the particles are believed to be substantially spherical in structure, dimensionally stable and do not change shape over time. The sol particles are mechanically soft and heavily hydrated which reduces surface damage even in the case where soft polymer or porous dielectric films are polished. The sol particles are formed of a chemically active metal oxide material, or combinations thereof, or can be coated on chemically inactive oxide material such as silicon dioxide or can be conformed therewith. The oxide sols can include a bi-modal particle distribution. The slurry can be utilized in CMP processes, with or without conditioning.
    Type: Grant
    Filed: April 27, 2000
    Date of Patent: October 15, 2002
    Assignee: Honeywell International Inc.
    Inventors: Daniel I. Towery, Michael A. Fury
  • Patent number: 6455690
    Abstract: Novel nucleosides having the structure of Formula 1 and Formula 2 are contemplated. In one aspect of the invention, controlled release dosage forms are particularly contemplated. Further, alternative routes of administration of the nucleosides having the structure of Formula 1 or Formula 2 are contemplated.
    Type: Grant
    Filed: June 15, 2000
    Date of Patent: September 24, 2002
    Inventors: Robert Tam, Devron Averett, Guangyi Wang, Kanda Ramasamy